Line 30: | Line 30: | ||
<a href="/Team:Tongji_China/P.A." class="test_a"><img src="https://static.igem.org/mediawiki/2018/a/a7/T--Tongji_China--picture-Project-Background-Overview-3_P.A..png" class="linkpicture3"></a></p> | <a href="/Team:Tongji_China/P.A." class="test_a"><img src="https://static.igem.org/mediawiki/2018/a/a7/T--Tongji_China--picture-Project-Background-Overview-3_P.A..png" class="linkpicture3"></a></p> | ||
<br><br><br> | <br><br><br> | ||
− | </div style="margin-left:50px"> | + | </div> |
− | <a href="https://2018.igem.org/Team:Tongji_China/Project">Return to the Project Overview</a> | + | <div style="margin-left:50px"> |
+ | <a href="https://2018.igem.org/Team:Tongji_China/Project">Return to the Project Overview</a></div> | ||
<br><br> | <br><br> | ||
</div> | </div> |
Revision as of 04:01, 13 October 2018
Background
Overview
In this section, you can get a deep version of various cancer therapies nowadays, and also the promising concept - “Neoantigen”, which occurs recently. We would like to introduce the surprising protein delivery tool – Type III secretion system (T3SS) we used in our project and the engineered bacteria – attenuated Pseudomonas aeruginosa.